EURETINA 2023: Safety and efficacy through week 48 in the Phase 2a STARLIGHT clinical trial
October 6th 2023We spoke with Michael Singer, MD who provided an overview of his presentation, "MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial"